{"id":2457,"date":"2026-04-27T15:20:10","date_gmt":"2026-04-27T15:20:10","guid":{"rendered":"https:\/\/tattvatrials.com\/?page_id=2457"},"modified":"2026-06-22T13:40:29","modified_gmt":"2026-06-22T13:40:29","slug":"rfpk1991-pediatric-acute-diarrhea","status":"publish","type":"page","link":"https:\/\/tattvatrials.com\/index.php\/rfpk1991-pediatric-acute-diarrhea\/","title":{"rendered":"Pediatric Acute Diarrhea (ACTIVE)"},"content":{"rendered":"\n<div class=\"wp-block-group is-nowrap is-layout-flex wp-container-core-group-is-layout-8f761849 wp-block-group-is-layout-flex\">\n<p class=\"has-text-align-left wp-block-paragraph\">We are actively recruiting for a study assessing the pharmacokinetics of  XIFAXAN\u00ae 200 mg in pediatric participants 6 to 11 years of age with acute diarrhea of suspected bacterial etiology, and the safety and efficacy of XIFAXAN\u00ae 200 MG plus oral rehydration therapy (ORT) compared to ORT alone. If you have a child between 6-11 years old with diarrhea and a fever, they may qualify for the study. Participation will last approximately 1 month with 4 clinic visits in the first week and phone call follow-ups in each week thereafter; compensation is up to $825 and includes meals for longer in-clinic visits. If you are interested in learning more about the study, please call or email us!<\/p>\n<\/div>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"791\" height=\"1024\" src=\"https:\/\/tattvatrials.com\/wp-content\/uploads\/2026\/06\/IMG_5013-1-791x1024.jpeg\" alt=\"\" class=\"wp-image-2512\" srcset=\"https:\/\/tattvatrials.com\/wp-content\/uploads\/2026\/06\/IMG_5013-1-791x1024.jpeg 791w, https:\/\/tattvatrials.com\/wp-content\/uploads\/2026\/06\/IMG_5013-1-232x300.jpeg 232w, https:\/\/tattvatrials.com\/wp-content\/uploads\/2026\/06\/IMG_5013-1-768x994.jpeg 768w, https:\/\/tattvatrials.com\/wp-content\/uploads\/2026\/06\/IMG_5013-1-1187x1536.jpeg 1187w, https:\/\/tattvatrials.com\/wp-content\/uploads\/2026\/06\/IMG_5013-1.jpeg 1545w\" sizes=\"auto, (max-width: 791px) 100vw, 791px\" \/><\/figure>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>We are actively recruiting for a study assessing the pharmacokinetics of XIFAXAN\u00ae 200 mg in pediatric participants 6 to 11 years of age with acute diarrhea of suspected bacterial etiology,&#8230;<\/p>\n","protected":false},"author":1,"featured_media":1644,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"give_campaign_id":0,"_EventAllDay":false,"_EventTimezone":"","_EventStartDate":"","_EventEndDate":"","_EventStartDateUTC":"","_EventEndDateUTC":"","_EventShowMap":false,"_EventShowMapLink":false,"_EventURL":"","_EventCost":"","_EventCostDescription":"","_EventCurrencySymbol":"","_EventCurrencyCode":"","_EventCurrencyPosition":"","_EventDateTimeSeparator":"","_EventTimeRangeSeparator":"","_EventOrganizerID":[],"_EventVenueID":[],"_OrganizerEmail":"","_OrganizerPhone":"","_OrganizerWebsite":"","_VenueAddress":"","_VenueCity":"","_VenueCountry":"","_VenueProvince":"","_VenueState":"","_VenueZip":"","_VenuePhone":"","_VenueURL":"","_VenueStateProvince":"","_VenueLat":"","_VenueLng":"","_VenueShowMap":false,"_VenueShowMapLink":false,"_kadence_starter_templates_imported_post":false,"_kad_post_transparent":"default","_kad_post_title":"default","_kad_post_layout":"default","_kad_post_sidebar_id":"default","_kad_post_content_style":"boxed","_kad_post_vertical_padding":"hide","_kad_post_feature":"default","_kad_post_feature_position":"default","_kad_post_header":false,"_kad_post_footer":false,"footnotes":""},"class_list":["post-2457","page","type-page","status-publish","has-post-thumbnail","hentry"],"campaignId":"0","_links":{"self":[{"href":"https:\/\/tattvatrials.com\/index.php\/wp-json\/wp\/v2\/pages\/2457","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tattvatrials.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/tattvatrials.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/tattvatrials.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/tattvatrials.com\/index.php\/wp-json\/wp\/v2\/comments?post=2457"}],"version-history":[{"count":11,"href":"https:\/\/tattvatrials.com\/index.php\/wp-json\/wp\/v2\/pages\/2457\/revisions"}],"predecessor-version":[{"id":2519,"href":"https:\/\/tattvatrials.com\/index.php\/wp-json\/wp\/v2\/pages\/2457\/revisions\/2519"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tattvatrials.com\/index.php\/wp-json\/wp\/v2\/media\/1644"}],"wp:attachment":[{"href":"https:\/\/tattvatrials.com\/index.php\/wp-json\/wp\/v2\/media?parent=2457"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}